An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity

(2020) Chaya D. Patel et al.   JOURNAL OF VIROLOGY

Vaccines to prevent genital herpes

(2020) Kevin Egan et al.   Translational Research

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

(2020) Kevin Egan et al.   Human Vaccines & Immunotherapeutics

Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity

(2019) Chaya D. Patel et al.   Science Translational Medicine

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

(2019) Sita Awasthi et al.   VACCINE

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

(2019) Sita Awasthi et al.   Science Immunology

Time Trends in First-Episode Genital Herpes Simplex Virus Infections in an Urban Sexually Transmitted Disease Clinic

(2019) Nazila Dabestani et al.   SEXUALLY TRANSMITTED DISEASES

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

(2018) Norbert Pardi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease

(2017) Yike Jiang et al.   mBio

Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study

(2017) Christine Johnston et al.   PLOS MEDICINE

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs

(2017) Sita Awasthi et al.   PLoS Pathogens

Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model

(2015) Marina Boukhvalova et al.   JOURNAL OF VIROLOGY

Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012

(2015) Katharine J. Looker et al.   PLoS One

Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012

(2015) Katharine J. Looker et al.   PLoS One

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

(2014) Sita Awasthi et al.   JOURNAL OF INFECTIOUS DISEASES

Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes

(2014) S. Awasthi et al.   JOURNAL OF VIROLOGY

Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women

(2013) R. B. Belshe et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy Results of a Trial of a Herpes Simplex Vaccine

(2012) Robert B. Belshe et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo

(2011) J. M. Lubinski et al.   JOURNAL OF VIROLOGY

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

(2011) S. Awasthi et al.   JOURNAL OF VIROLOGY

A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine

(2008) E. E. Brittle et al.   JOURNAL OF VIROLOGY